Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Pancreatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Opioid-Related Disorders 1Opioid-Induced Constipation 1Neoplasms 1Constipation 1

Interventions

alvimopan 6tegaserod 3naloxegol 2Standard of Care 2Naloxone 2polyethylene glycol 3350 1oxycodone-acetaminophen 1oxycodone naloxone combination 1naldemedine 1methylnaltrexone 1ma zi ren wan 1isatuximab 1Videotape Recording 1Tramadol 1Sutures 1Surveys and Questionnaires 1Surgical Instruments 1Sennosides 1Quality of Life 1Proteins 1Phenolphthalein 1Oxycodone 1Orphenadrine 1Octreotide 1Nicotine 1Morphine 1Methadone 1Lidocaine 1Ketorolac Tromethamine 1Ketorolac 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Constipation × methylnaltrexone × Clear all
NCT01004393 2016-02-02

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

University of Vermont

Phase 2 Completed
12 enrolled 10 charts
Other

Constipation, Opioid-Related Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡